What is the most important question to ask in early phase clinical drug development?
-
Chair(s):
Professor Geert Jan Groeneveld,
CSO/CMO,Centre for Human Drug Research, Leiden, The Netherlands -
Session description:
Question based drug development and beyond
Professor Dr Koos Burggraaf
CEO, Centre for Human Drug Research, NetherlandsDe-risking FIH studies
Dr Jules Heuberger
Associate Research Director Experimental Medicine, Centre for Human Drug Research, Leiden, The NetherlandsProof-of-pharmacology in early phase clinical drug studies
Professor Geert Jan Groeneveld
CSO/CMO,Centre for Human Drug Research, Leiden, The NetherlandsAccelerated proof-of-concept in early clinical development
Professor Robert Rissmann
Research Director, Centre for Human Drug Research, Leiden, The NetherlandsAnalysis of wearables generated data as pharmacological biomarkers using AI
Ahnjili Zhuparris
Data Scientist, Centre for Human Drug Research, Leiden, The NetherlandsSponsored by:
Speakers
-
Ahnjili ZhuparrisData Scientist, Centre for Human Drug Research, Leiden, The Netherlands
-
Dr Jules HeubergerAssociate Research Director Experimental Medicine, Centre for Human Drug Research, Leiden, The Netherlands
-
Professor Geert Jan GroeneveldCSO/CMO,Centre for Human Drug Research, Leiden, The Netherlands
-
Professor Robert Rissmann Research Director, Centre for Human Drug Research, Leiden, The NetherlandsProfessor Robert RissmannResearch Director, Centre for Human Drug Research, Leiden, The Netherlands
Leave A Comment